About The Journal Open Access

Journal of Clinical Oncology and Cancer Research publishes research work on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials. Journal mainly focusses on clinical research that impact on the diagnosis and treatment of cancer using surgery, diagnostic imaging, interventional therapeutics, and surgical pathology and all aspects of Cancer epidemiology including risk factors for disease initiation and development, social determinants, environmental, behavioural, and occupational correlates. Journal of Clinical Oncology and Cancer Research is an international peer reviewed, open access journal where articles are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Journal is indexed in Publons and Google scholar. Journal undergoes single blind peer review process, eminent reviewers are assigned for reviewing and subsequent decision is taken by the section of editors. The journal follows online editorial tracking system for quality tracking of the manuscripts. The Journal is seeking manuscripts that include significant advances in basic cancer research that offers understanding, prevention, diagnosis and treatment of cancer.
Authors are requested to submit manuscript at Online Submission System or as an e-mail attachment at [email protected] / [email protected] Individuals interested in becoming members of the Editorial/Review Board should contact by email.
H-index
Articles published in Journal of Clinical Oncology and Cancer Research have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Oncology and Cancer Research has got H-index 1 , which means every article in Journal of Clinical Oncology and Cancer Research has got 1 average citations.
[email protected]
Just Published Articles View More
Opinion Article December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
Risk study utilising Medicare claims data: Initial and recurrent thromboembolic disease rates in individuals with and without cancer.
Choi Sasha
Rapid Communication December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
An study of current chemotherapeutic methods for treating humans
Peter Babo
Short Communication December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
Human African trypanosomiasis chemotherapy: present and future prospects.
Bobo Lin
Mini Review December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
Radiation treatment controlling the adverse effects
Koong Lei
Perspective December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
Has screening had a significant influence on colorectal cancer incidence and mortality?
Balducci Rawla
Opinion Article December 07, 2022
P.1-2
J Clin Oncol Cancer Res: 5(5): 1-2
Cancer care healthcare quality significant changes.
Wolfgang Dorr
DOI: